These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 10574926)
1. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. Pennathur S; Jackson-Lewis V; Przedborski S; Heinecke JW J Biol Chem; 1999 Dec; 274(49):34621-8. PubMed ID: 10574926 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. Leeuwenburgh C; Rasmussen JE; Hsu FF; Mueller DM; Pennathur S; Heinecke JW J Biol Chem; 1997 Feb; 272(6):3520-6. PubMed ID: 9013599 [TBL] [Abstract][Full Text] [Related]
3. Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats. Leeuwenburgh C; Hansen P; Shaish A; Holloszy JO; Heinecke JW Am J Physiol; 1998 Feb; 274(2):R453-61. PubMed ID: 9486304 [TBL] [Abstract][Full Text] [Related]
4. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Heinecke JW Toxicology; 2002 Aug; 177(1):11-22. PubMed ID: 12126792 [TBL] [Abstract][Full Text] [Related]
6. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [TBL] [Abstract][Full Text] [Related]
7. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice. Selley ML Brain Res; 2005 Mar; 1037(1-2):1-6. PubMed ID: 15777746 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity. Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147 [TBL] [Abstract][Full Text] [Related]
9. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. Pennathur S; Wagner JD; Leeuwenburgh C; Litwak KN; Heinecke JW J Clin Invest; 2001 Apr; 107(7):853-60. PubMed ID: 11285304 [TBL] [Abstract][Full Text] [Related]
10. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Choi JY; Jang EH; Park CS; Kang JH Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991 [TBL] [Abstract][Full Text] [Related]
11. Submolecular adventures of brain tyrosine: what are we searching for now? Kochman A; Kośka C; Metodiewa D Amino Acids; 2002; 23(1-3):95-101. PubMed ID: 12373523 [TBL] [Abstract][Full Text] [Related]
12. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. Heinecke JW; Li W; Francis GA; Goldstein JA J Clin Invest; 1993 Jun; 91(6):2866-72. PubMed ID: 8390491 [TBL] [Abstract][Full Text] [Related]
13. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058 [TBL] [Abstract][Full Text] [Related]
14. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060 [TBL] [Abstract][Full Text] [Related]
15. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice. Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress. Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429 [TBL] [Abstract][Full Text] [Related]
17. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain. Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773 [TBL] [Abstract][Full Text] [Related]
18. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
19. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease. Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664 [TBL] [Abstract][Full Text] [Related]